Recent Advances in Genetics and Molecular Biology in Global Neurology

Integrated Neuroscience Session

Monday, April 27, 2:00–6:00 p.m.

The pace of discoveries in neurogenetics and molecular biology has increased dramatically. Although research has tended to focus on diseases that differentially impact high-income countries, these research tools are recently being applied more frequently to disease more prevalent in lower income countries. Furthermore, global variation in disease prevalence has been used as a tool to define the underlying genetics of some diseases. Variation in regional regulation will continue to impact opportunities for future research.

Discussion Session: 2:00–3:30 p.m.
  • 2:00–2:20 p.m. Neurological Disease on the Global Agenda, Julie Jacobson
  • 2:20–2:40 p.m. The Genetics of Multiple Sclerosis and Global Disease Variation, Stephen L. Hauser, MD
  • 2:40–3:00 p.m. Neurogenetics: The European Perspective, Christine Klein, MD
  • 3:00–3:20 p.m. Neurogenetics: The US Perspective, Fuki Hisama, MD
  • 3:20–3:30 p.m. Discussion and Questions
Poster Session: 3:30–4:30 p.m.
  • IN2-1.001 A new RAB7 mutation in a large French Charcot-Marie-Tooth 2B family, Emmanuelle Salort-Campana, MD
  • IN2-1.002 Founder Effect and New Mutations of SPG11 in French-Canadians Families, Inge Meijer, PhD
  • IN2-1.003 Variable Phenotypic Expression of Rapid Onset Dystonia Parkinsonism in a Newly Discovered Italian Family with a T613M Mutation in the ATP1A3 Gene, Richard L. Barbano, MD, PhD
  • IN2-1.004 Environmental Risk Factors and Quality of Life in Leber Hereditary Optic Neuropathy, Matthew A. Kirkman, BSc
  • IN2-1.005 Neurological Relevance of the Intrathecal Specific Humoral Immune Response Analysis in Dengue Infection, Marzia Puccioni-Sohler, MD, PhD
  • IN2-1.006 A large number of SACS mutations are responsible for ARSACS in the French-Canadian population, Isabelle Thiffault, BSc, MSc
  • IN2-1.007 Two Novel CYP7B1 Mutations in Italian Families with Autosomal Recessive Spastic Paraplegia: A Clinical and Genetic Study, Chiara Criscuolo, MD
  • IN2-1.008 A Novel Association of ATP-Binding Cassette Family gene (ABCB1) Among South Indian Patients with Epilepsy, Abhijit Das, MD
  • IN2-1.009 Allelic Associations of ANG with Sporadic ALS in Irish and Swedish Patients, Julie Phukan, MB
  • IN2-1.010 IFNβ-Pathway Gene Polymorphisms Influence Response to Multiple Sclerosis Treatment: A European Study, Nicolas Couturier, PhD
Platform Session: 4:30–6:00 p.m.
  • IN2-2.001 Ongoing Genomewide Association in Familial Intracranial Aneurysm, Daniel L. Koller, PhD
  • IN2-2.002 Toll-like Receptors Are Critical for Protection against West Nile Virus Infection, Amir H. Sabouri, MD, PhD
  • IN2-2.003 Viral risk factors of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), Amir H. Sabouri, MD, PhD
  • IN2-2.004 Parental Consanguinity is Associated with a Higher Incidence Rate of Progressive Encephalopathy: A Cohort Study, Petter Stromme, MD, PhD
  • IN2-2.005 Epistasis among HLA-DRB1, HLA-DQA1 and HLA-DQB1 loci determines multiple sclerosis susceptibility, Matthew R. Lincoln, DPhil
  • IN2-2.006 Phenotypic spectrum of Laing distal myopathy in four Spanish families with Lys1729del mutation, Nuria Muelas, MD
For More Information

Daniel Tarsy's picture
Daniel Tarsy MD, FAAN
Chair

Erin Jackson's picture
Erin Jackson
Senior Administrator, Scientific Programs
ejackson@aan.com
(651) 695-2704